These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8707249)

  • 1. Increased levels of soluble complement receptor 1 in serum patients with liver diseases.
    Sadallah S; Giostra E; Mentha G; Schifferli JA
    Hepatology; 1996 Jul; 24(1):118-22. PubMed ID: 8707249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its release by human leukocytes.
    Pascual M; Duchosal MA; Steiger G; Giostra E; Pechère A; Paccaud JP; Danielsson C; Schifferli JA
    J Immunol; 1993 Aug; 151(3):1702-11. PubMed ID: 8335953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The changes and significance of red cell nature-immune-adhesion function in liver diseases at different stages].
    Wang HB; Zhang JW; Guo JX; Liu ZH
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(6):455-8. PubMed ID: 12887755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble complement receptor type 1 (sCR1) in chronic liver diseases: serum levels at different stages of liver diseases.
    Di Bona D; Montalto G; Clemenza L; Bascone F; Accardo P; Bellavia D; Craxì A; Brai M
    Clin Exp Immunol; 1998 Oct; 114(1):102-5. PubMed ID: 9764610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients.
    Kanto T; Hayashi N; Takehara T; Katayama K; Kato M; Akiyama M; Kasahara A; Fusamoto H; Kamada T
    J Med Virol; 1996 Oct; 50(2):126-34. PubMed ID: 8915878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between thrombopoietin serum levels and liver function in patients with chronic liver disease related to hepatitis C virus infection.
    Giannini E; Botta F; Borro P; Malfatti F; Fumagalli A; Testa E; Podestà E; Chiarbonello B; Polegato S; Mamone M; Testa R
    Am J Gastroenterol; 2003 Nov; 98(11):2516-20. PubMed ID: 14638357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Decrease of haptoglobin serum level in patients with chronic viral hepatitis C].
    Bacq Y; Schillio Y; Brechot JF; De Muret A; Dubois F; Metman EH
    Gastroenterol Clin Biol; 1993; 17(5):364-9. PubMed ID: 8349072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected].
    Kirmaz C; Terzioglu E; Topalak O; Bayrak P; Yilmaz O; Ersoz G; Sebik F
    Eur Cytokine Netw; 2004; 15(2):112-6. PubMed ID: 15319169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection.
    Migita K; Abiru S; Maeda Y; Daikoku M; Ohata K; Nakamura M; Komori A; Yano K; Yatsuhashi H; Eguchi K; Ishibashi H
    Hum Immunol; 2006; 67(1-2):27-32. PubMed ID: 16698422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of interleukin-10, interleukin-12 and soluble interleukin-2 receptor in chronic liver disease type C.
    Kitaoka S; Shiota G; Kawasaki H
    Hepatogastroenterology; 2003; 50(53):1569-74. PubMed ID: 14571788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue inhibitors of metalloproteinases in liver and serum/plasma in chronic active hepatitis C and HCV-induced cirrhosis.
    Böker KH; Pehle B; Steinmetz C; Breitenstein K; Bahr M; Lichtinghagen R
    Hepatogastroenterology; 2000; 47(33):812-9. PubMed ID: 10919037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay.
    Tsubouchi H; Niitani Y; Hirono S; Nakayama H; Gohda E; Arakaki N; Sakiyama O; Takahashi K; Kimoto M; Kawakami S
    Hepatology; 1991 Jan; 13(1):1-5. PubMed ID: 1824837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum concentration of adhesion molecules in postoperative biliary atresia patients: relationship to disease activity and cirrhosis.
    Kobayashi H; Horikoshi K; Long L; Yamataka A; Lane GJ; Miyano T
    J Pediatr Surg; 2001 Aug; 36(8):1297-301. PubMed ID: 11479880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High serum soluble CD30 does not predict acute rejection in liver transplant patients.
    Matinlauri I; Höckerstedt K; Isoniemi H
    Transplant Proc; 2006 Dec; 38(10):3601-4. PubMed ID: 17175343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
    Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores.
    Kiki I; Yilmaz O; Erdem F; Gundogdu M; Demircan B; Bilici M
    Int J Clin Pract; 2006 Sep; 60(9):1075-9. PubMed ID: 16939549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease].
    Kwon JH; Park ST; Kim GD; You CR; Kim JD; Woo HY; Jang JW; Kim CW; Bae SH; Choi JY; Yoon SK
    Korean J Hepatol; 2009 Mar; 15(1):59-69. PubMed ID: 19346786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of anticoagulant proteins in chronic liver diseases.
    Gürsoy S; Başkol M; Torun E; Yurci A; Soyuer I; Eser B; Güven K; Ozbakir O; Yücesoy M
    Turk J Gastroenterol; 2005 Sep; 16(3):129-33. PubMed ID: 16245221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid parameters predicting liver function in patients with cirrhosis and after liver transplantation.
    Tietge UJ; Boker KH; Bahr MJ; Weinberg S; Pichlmayr R; Schmidt HH; Manns MP
    Hepatogastroenterology; 1998; 45(24):2255-60. PubMed ID: 9951906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.